Ying Chen

Dr. Ying Chen

Translational Medicine Laboratory,Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2006 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YCYing Chen
Ying Chen
XDXiao‐Yan Du
Xiao‐Yan Du

1 June 2014 in Clinica Chimica Acta
Verified
Journal Article
Closed access
JMJun Mao
Jun Mao
TWTing Wang
Ting Wang
BWBen-Jing Wang
Ben-Jing Wang
YLYing-Hua Liu
Ying-Hua Liu
HLHong Li
Hong Li
YCYing Chen
Ying Chen

1 March 2020 in Environmental Research
Verified
Journal Article
Closed access
XYXu Yang
Xu Yang
MZMingzhi Zhang
Mingzhi Zhang
TLTing Lu
Ting Lu
SCShiyao Chen
Shiyao Chen
XSXian Sun
Xian Sun
Yankai XiaYankai Xia
Yankai Xia

1 November 2010 in Clinica Chimica Acta
Verified
Journal Article
Closed access
YCYing Chen
Ying Chen
JMJun Mao
Jun Mao
YSYing Sun
Ying Sun
QZQiang Zhang
Qiang Zhang
HCHong-Bo Cheng
Hong-Bo Cheng
HLHong Li
Hong Li

10 June 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
BWBenjing Wang
Benjing Wang
MLMinjuan Liu
Minjuan Liu
WYWenhua Yan
Wenhua Yan
JMJun Mao
Jun Mao
DJDong Jiang
Dong Jiang
YCYing Chen
Ying Chen
To investigate the association of 12 single nucleotide polymorphisms (SNPs) in folate metabolic genes with congenital heart disease (CHD). A total of 160 children with CHD and 188 control children were enrolled. Twelve SNPs related to folate metabolism, including CBS-C699T, DHFR-c594 + 59del19, FOLH1-T1561C, CBS-C699T, DHFR-c594 + 59del19, GSTO1-C428T, MTHFD-G878A and -G1958A, MTHFR-C677T and -A1298C, MTR-A2756G, MTRR-A66G, NFE2L2-ins1 + C11108T, RFC1-G80A, TCN2-C776T and TYMS-1494del6, were genotyped by SNaPShot genotyping technology and confirmed by Sanger sequencing. There were two SNPs including NFE2L2-ins1 + C11108T and GST01-C428T and two compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G), which might increase the risk of CHD, and DHFR-c594 + 59del19 might decrease the risk of CHD. The CT genotype of NFE2L2-ins1 + C11108T, OR = 2.15 (95% CI = [1.07, 4.32], p < 0.05). The CT + TT genotype of NFE2L2-ins1 + C11108T, OR = 1.98 (95% CI = [1.00, 3.93], p < 0.05). The TT genotype of GST01-C428T, OR = 3.49, (95CI% = [1.06, 11.5], p < 0.05). The GG genotype of DHFR-c594 + 59del19, OR = 0.46 (CI% = [0.24, 0.87], p < 0.05). The AG + GG genotype of DHFR-c594 + 59del19, OR = 0.53 (CI% = [0.29, 0.96], p < 0.05). The ratios of the two compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G) in CHD are higher than that in control, p < 0.05 (OR = 2.968, 95% CI = [1.022, 8.613]). The CT genotype of NFE2L2-ins1 + C11108T and the TT genotype of GST01-C428T are susceptible factors for CHD. The AG, GG and (AG + GG) genotypes of DHFR-c594 + 59del19 are protective genotypes for CHD. Compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G) may increase the risk of CHD.

10 March 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YWYibo Wu
Yibo Wu
YYyan yuan
yan yuan
LCLing Chen
Ling Chen
MWMin Wang
Min Wang
YYYong Yang
Yong Yang
TZTao Zhou
Tao Zhou
Seminal plasma is a complex mixture of secretions from various glands in the male genital tract. Compared to sperm cells, it contains important proteins that are both directly and indirectly associated with sperm motility. Here, we constructed quantitative proteomes of human seminal plasma from three normozoospermic and asthenozoospermic individuals. A total of 524 proteins were identified, and 366 of them were found to be quantified in all six samples. We first investigated the absolute expression features of these proteins and found that the variations of protein identification among different samples and other published datasets were mainly due to some lowly expressed proteins. By integration of various proteomic datasets and bioinformatics databases, we comprehensively annotated the biological functions, physiological originations, and disease associations of these proteins. We found that our dataset could benefit the studies of both male infertility and other male diseases. Finally, based on the relative expression values determined by chemical labeling, we identified a total of 29 differentially expressed proteins, which could be used as candidate targets for studying the molecular bases of sperm motility or developing precise diagnostic biomarkers of asthenozoospermia. We further successfully verified the expression trends of four representative proteins by Western blotting. Compared to a previous dataset based on label-free quantification, our results showed that most of the important proteins could be identified in the sample collected only once for each individual, providing the bases for personalized examination of seminal plasma proteins in clinic.